Authors
Loading...
Randomized trial shows new glycopeptide antibiotic inhibits bacterial growth in drug-resistant pathogens, indicating a promising alternative for treatment.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: